Trials / Completed
CompletedNCT03183323
Implementation of Telerehabilitation In Support of HOme-based Physical Exercise for Heart Failure
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 61 (actual)
- Sponsor
- Helse Nord-Trøndelag HF · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
ITISHOPE4HF is a randomized controlled trial of telerehabilitation in a heart failure population. The goal is to evaluate if a home-based telerehabilitation project can increase physical activity in heart failure patients. Patients will be provided telerehabilitation or advice on physical activity (standard care).
Detailed description
Outpatient cardiac rehabilitation programs are well documented as an important part of treatment and care for heart failure patients. Training with instruction gives the participant a commitment to participate. The result is increased activity compared to controls. This trial will include participants from the about 75 % of heart failure patients who for some reason do not participate in regular outpatient rehabilitation. Distance to rehabilitation centers and the psychological burden of a group setting are believed to be important reasons for not participating. Telerehabilitation can hopefully overcome these hurdles for many patients, and thereby provide instructed training for these patients. The trial will also include patients with renal disease. Heart disease is the main cause of death in patients with renal disease, even at younger ages. Because of the complexity of both optimal medical treatment and fluid balance, these patients are often not included in clinical trials. The cardiorenal crosstalk will be explored, how in influence the heart failure phenotypes and the response to exercise.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Telerehabilitation | Activity trackers. Mio Slice is worn through the whole study. Actigraph is worn for one week, at 4 different timepoints through the study. |
Timeline
- Start date
- 2017-06-08
- Primary completion
- 2021-02-28
- Completion
- 2021-02-28
- First posted
- 2017-06-12
- Last updated
- 2022-04-14
Locations
1 site across 1 country: Norway
Source: ClinicalTrials.gov record NCT03183323. Inclusion in this directory is not an endorsement.